Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis
J Dtsch Dermatol Ges. 2024 Feb;22(2):278-281. doi: 10.1111/ddg.15292. Epub 2024 Jan 7.
NO ABSTRACT
PMID:38185772 | DOI:10.1111/ddg.15292